Skip to content
Home/Companies/Healthcare / Biotech/Breath Therapeutics

Breath Therapeutics

Healthcare / Biotech·Germany·Exited 2019·Held 3yr
Entry
2016
Hold
3yr
Exit
2019

Who owns Breath Therapeutics?

Breath Therapeutics was owned by Sofinnova Partners through Sofinnova Capital VIII (2015 vintage) from 2016 to 2019, exited via Trade Sale. Across its history, Breath Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Most recent investor
Sofinnova Partners
Sofinnova Capital VIII · 2015 · Life Sciences VC
2 ownership periods · full history below

Key facts

HQGermany
SectorHealthcare / Biotech
Key takeaways
  • ·Fully exited in 2019.
  • ·Average hold across 2 realized cycles: 3 years.

Ownership history

2 ownership periods · co-invest detected

Exited
Last exited in 2019 to .
Co-invest · 2 holders · 2016 · 2019
Sofinnova Partners
Sofinnova PartnersExited 2019
2016 · 2019(3yr) · Sofinnova Capital VIII · 2015 · Life Sciences VC
Trade Sale · to
MOIC
–
Gimv
GimvExited 2019
2016 · 2019(3yr) · Gimv Portfolio
Trade Sale · to
MOIC
–

More from Sofinnova Capital VIII

Other portfolio companies in the same fund.

VectivBio
Exited 2023
BiotechSwitzerland· 2017
to
Corvidia Therapeutics
Exited 2020
BiotechUS· 2016
to
Delinia
Exited 2017
BiotechUK· 2016
to
ENYO Pharma
ENYO Pharma
Active
BiotechFrance· 2016
ReCor Medical
Exited 2018
MedTechUS· 2016
to
BiovelocITA
Active
BiotechItaly· 2015

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Breath Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Breath Therapeutics?

8 strategic and 112financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Breath Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue